Corvus Pharmaceuticals, Inc. (CRVS)

CIK 1626971 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Corvus Pharmaceuticals, Inc..

Recent SEC filings

FiledFormAccession number
Aug 7, 2026SCHEDULE 13G0000093751-26-000443
Aug 6, 202610-Q0001104659-26-091975
Aug 6, 20268-K0001171843-26-005317
Jul 27, 2026SCHEDULE 13G/A0002012383-26-002292
Jul 22, 20268-K0001104659-26-085790
Jun 15, 202640001610717-26-000223
Jun 15, 202640001610717-26-000219
Jun 15, 202640001610717-26-000220
Jun 15, 202640001610717-26-000221
Jun 15, 202640001610717-26-000222
Jun 12, 20268-K0001171843-26-004094
May 20, 202640001610717-26-000160
May 15, 2026SCHEDULE 13G0000919574-26-003217
May 15, 2026SCHEDULE 13G/A0000919574-26-003462
May 14, 20268-K0001171843-26-003397
May 7, 20268-K0001171843-26-003154
May 7, 2026S-80001104659-26-057263
May 7, 202610-Q0001104659-26-057100
Apr 27, 2026SCHEDULE 13G/A0002012383-26-001739
Apr 27, 202640001610717-26-000149
Apr 27, 202630001610717-26-000148
Apr 24, 2026DEF 14A0001104659-26-048595
Apr 24, 2026DEFA14A0001104659-26-048600
Apr 23, 20268-K0001104659-26-047735
Mar 26, 2026SCHEDULE 13G/A0000102909-26-001004